Nefarious design of Mucormycosis in COVID-19 cases in India: A case report

Authors

  • Kriti Gupta Director and Consultant Microbiologist, Dr. Niraj Kumar Gupta Micro Path Lab, Bijnor, Uttar Pradesh, India
  • Sangeeta Demonstrator,Department of Community Medicine, Kalpana Chawla Medical College, Karnal, Haryana, India
  • Sonali Department of Pathology,Kalpana Chawla Medical College, Karnal, Haryana, India
  • Himani Dureja Junior Resident,Department of Ophthalmology,Kalpana Chawla Medical College, Karnal Haryana, India
  • Anupam Berwal Assistant Professor,Department of Microbiology, Kalpana Chawla Medical College, Karnal Haryana, India

Keywords:

COVID-19, Mucormycosis, India.

Abstract

India has encountered a de novo problem of deaths due to Mucormycosis in some patients treated for COVID-19. Under mentioned is a case of COVID-19 later complicated with mucormycosis who succumbed prior to any surgical intervention could possibly be performed.

Downloads

Published

2021-08-16

How to Cite

Kriti Gupta, Sangeeta, Sonali, Himani Dureja, & Anupam Berwal. (2021). Nefarious design of Mucormycosis in COVID-19 cases in India: A case report. International Journal of Health and Clinical Research, 4(14), 4–5. Retrieved from https://ijhcr.com/index.php/ijhcr/article/view/2214

Issue

Vol. 4 No. 14 (2021): Volume 4 Issue 14| July 2021

Section

Articles

License

Copyright (c) 2021 Kriti Gupta, Sangeeta, Sonali, Himani Dureja, Anupam Berwal

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.